To address the role of follicular angiogenesis in the determination of ovulatory follicles and the effects of different vascular endothelial growth factor (VEGF) isoforms on follicular angiogenesis and development, mature female rats were treated with an angiogenic inhibitor (TNP-470), and also with VEGF 120 or 164 at different dosages (0.4, 0.8, 4.0 or 8.0 µg/kg body weight) for 3 days during the estrous cycle. Ovarian follicular angiogenesis, the population of large follicles and ovulation were examined. VEGF 120 (0.8 µg/kg) and 164 (8.0 µg/kg) treatments stimulated follicular angiogenesis in the theca interna layer, while TNP-470 treatment showed severe depression of follicular angiogenesis, and completely inhibited ovulation. After administration of VEGF 120 or 164, the number of healthy preovulatory follicles and ovulated oocytes increased significantly, concomitantly with a decrease in the number of atretic preovulatory follicles. The oocytes ovulated had normal fertilizability and developed to term with the same litter size as in the control rats. Our findings suggest that follicular angiogenesis may be a determinant of follicular development during the periovulatory phase, and that VEGF isoforms may play different important roles in regulating follicular angiogenesis.
hile small preantral follicles have no vascular supply of their own, antral follicles acquire vascular networks in the thecal layer; the vascular capillaries do not penetrate the follicular membrane but they expand during follicular growth [1] . After formation of follicular microvasculature, the preferential delivery of gonadotropins via a more highly developed vascular network in individual follicles plays an instrumental role in growth of preovulatory follicles [2] . In turn, the decreased proliferation of vascular endothelial cells in the thecal layer of follicles leads to reduced thecal angiogenesis, which is thought to result in follicular cell apoptosis and atresia [3, 4] . Thus, angiogenesis is initiated in early follicular development and continues throughout follicular growth [3] .
Follicular thecal angiogenesis is regulated by a majority of the known angiogenic factors. Especially, epidermal growth factor (EGF), fibroblast growth factor (FGF), angiopoetins and vascular endothelial growth factor (VEGF) have been shown to be involved in the thecal angiogenic process of follicular development [5, 6] , of which VEGF is the most potent and specific angiogenic factor [7, 8] . With regard to the molecular mechanisms controlling follicular angiogenesis, the action of VEGF on ovarian follicular growth has been examined [9, 10] . A study using VEGF TrapA40 as a VEGF antagonist indicated that VEGF is the major inducer of vascular development during follicular growth in primates [11] . Moreover, VEGF Trap R1R2, which contains the extracellular domains of two VEGF receptors, fmslike tyrosine kinase (Flt-1) and fetal liver kinase (Flk-1), caused suppression of thecal angiogenesis in secondary and tertiary follicles throughout the follicular phase of the estrous cycle in primates [12] . These results demonstrate that the VEGF-Flt-1/Flk-1 system can modulate follicular angiogenesis with resultant follicle development.
The studies cited above together with others s h o w t h a t f o l l i c u l a r a n g i o g e n e s i s a n d microvasculature induced by VEGF play important roles in follicular development and atresia, suggesting that follicular angiogenesis may be a determinant of follicular fate. However, there is no direct evidence to support this hypothesis. The use of angiogenic inhibitors or injection of VEGF helps us to address it. TNP-470, an angiogenic inhibitor, has been used effectively to inhibit tumor growth [13, 14] , and it inhibits migration as well as proliferation of HUVECs [15] . In addition, the formation, development and function of the corpus luteum are greatly inhibited by anti-angiogenic d r u g s , i n c l u d i n g T N P -4 7 0 , a s a r e s u l t o f suppression of corpus luteum angiogenesis [16, 17] .
A single human VEGF gene generates seven isoforms of 110, 115, 121, 145, 165, 189 and 206 amino acids by alternative splicing [18] [19] [20] . Rodent VEGF is shorter by one amino acid than human VEGF [20, 21] . Although six VEGF isoforms (VEGF 110, 120, 144, 164, 188 and 205) have been detected in rat tissues [22] , only VEGF 120 and VEGF 164 have been observed in rat ovaries [23] . These two isoforms have also been detected in porcine ovaries and have been shown to be involved in follicular angiogenesis and development [5] . While VEGF isoforms have different biological functions [24] , the detailed biological differences among these isoforms during follicular angiogenesis and development remain unknown.
In the present study, to obtain direct evidence for promotion of follicular growth by injection of these VEGFs and to clarify the biological action of two V E G F i s o f o r m s o n f o l l i c u l a r g r o w t h , w e administered two VEGF isoforms (VEGF 120 and 164) to mature female rats. Capillary networks in the thecal layer and populations of follicles were assessed using ovarian corrosion casts and histological observations, respectively. The normality of oocytes ovulated after administration o f V E G F i s o f o r m s w a s e s t i m a t e d b y t h e i r fertilizability and developmental competence to term in vivo.
Materials and Methods

Animal preparation
Mature Wistar-Imamichi female rats (7 to 9 months old with body weight of 250 to 350 g) were maintained on a 14 L: 10 D photoperiod with food and water supplied ad libitum. Only those rats showing at least two consecutive 4-day estrous cycles were used in the experiments. The present study was approved by the Ethics Committee for C a r e a n d U s e o f L a b o r a t o r y A n i m a l s f o r Biomedical Research of the Graduate School of Agricultural Science, Tohoku University.
Treatment of TNP-470
TNP-470 (a kind gift of Takeda Chemical Industries, Ltd. Osaka, Japan) was suspended in a vehicle composed of 0.5% (v/v) ethanol plus 5% (w/v) arabic gum in saline. The animal subjects were randomly divided into two groups, one for each of the following treatments: (1) subcutaneous injection of TNP-470 at a dose of 45 mg/kg or (2) vehicle. Treatments were given in the morning on day 1 (metestrus) and day 2 (diestrus) [14] . The ovaries and oviducts were collected from the animals 24 and 48 h after the second injection, respectively.
VEGF 120 and 164 injection
To investigate the effects of VEGF 120 and 164 on follicular angiogenesis and development, and ovulation, the animals were intraperitoneally in j ec t e d wi t h V E G 
Assessment of thecal capillaries by scanning electron microscopy (SEM) of corrosion casts
Samples of corrosion casts from rats at proestrus were prepared for SEM observation as described in previous reports [25, 26] . Briefly, after the animals were anesthetized by a combination of ketamin (100 mg/kg; Sankyo Co. Ltd., Tokyo, Japan) and xylazine (5 mg/kg; Bayer, Leverkusen, Germany), they were perfused with heparinized saline solution followed by a solution of Mercox (Okenshoji, Tokyo, Japan) through the left ventricle. The cast ovaries were then warmed in hot water (60 C) for 2 h, corroded in 10% (w/v) NaOH at 60 C, washed in tap water, and then dried in a hot oven. The dried samples were glued onto aluminum stubs and coated with platinum. They w e r e e x a m i n e d w i t h a s c a n n i n g e l e c t r o n microscope (S-4200; Hitachi Tokyo, Japan).
Histological examination of follicular population
Just before treatment for corrosion casts, the right o v a r i e s w e r e c o l l e c t e d f r o m t h e a n i m a l s . Immediately after collection, the ovaries were fixed in 10% (v/v) neutral buffered formalin solution, embedded in paraffin, and cut at a thickness of 7 µm. Every 5th section was mounted and stained with hematoxylin and eosin. All antral follicles larger than 500 µm in diameter, which would be ovulated ones, were counted. To avoid counting individual follicles more than once, the oocytes with nuclei were used as a marker, and the size of each follicle was measured by an ocular micrometer when the nucleus of the oocyte was present. Each follicle was classified as either healthy or atretic as identified by the presence of 10 pyknotic bodies in the granulosa cells of each section [5] .
Serum 17β-estradiol level
Blood was collected from the animals before removal of the ovaries. Serum was immediately separated by centrifugation (3,000 g, 10 min.) and stored at -40 C until assay. Serum 17β-estradiol concentration was determined by using a DELFIA estradiol reagents R056-101 kit (Amersham Biosciences, Piscataway, NJ, USA), as previously reported [27] .
Assessment of fertilizability and developmental competence of the ovulated oocytes
To determine the fertilizability of ovulated oocytes, the animals treated with VEGF were mated with a fertility proven male on the day of proestrus. On the following day (estrus), mating was confirmed by observing the presence of sperm in the smear, and then oocytes were collected from the animals by flushing the oviducts. After counting the number of the oocytes ovulated, oocytes were estimated to be fertilized when the egg had pronuclei with a sperm tail in the vitellus, while the ones without intact zona pellucida and/ or homogenous cytoplasm were considered to be degenerated [28, 29] .
To determine the developmental competence of oocytes ovulated in VEGF-treated females, they were paired at proestrus with a fertility proven male. On the following day, the females were checked for vaginal spermatozoa to confirm copulation, and were kept separately in cages to allow delivery. After delivery, the numbers of pregnancies and offspring delivered, and the body weight of each pup were recorded.
Statistical analysis
All data were presented as mean ± SEM and were analyzed by ANOVA followed by Fisher's PLSD as a multiple comparison test using StatView (version 4.5, SAS Institute Inc., Cary, California, USA) software. Differences were considered significant at P<0.05.
Results
Effects of angiogenic inhibitor TNP-470 on follicular microvasculization and ovulation:
Mature rats treated with a subcutaneous injection of TNP-470 showed severe degeneration of follicular angiogenesis (Fig. 1 d) . In addition, TNP-470 treatment inhibited ovulation; the numbers of oocytes ovulated were 9.7 ± 0.3 vs 0 in rats injected with vehicle and TNP-470, respectively.
Follicular microvasculature in rats treated with VEGF:
Preovulatory follicles in the ovaries of rats treated with either of VEGF 120, VEGF 164 or PBS had spherical meshworks of capillaries. Active angiogenesis as indicated by capillary sprouting was observed in preovulatory follicular plexuses of rats treated with VEGF 120 or 164 at a dose of 0.8 or 8.0 µg/kg, respectively. The capillary densities in the theca internal layers of these preovulatory follicles were higher than those in controls (Figs. 1  a, b and c) .
Follicular population and serum 17β-estradiol level after VEGF treatment:
The number of healthy preovulatory follicles was significantly higher in the ovaries treated with VEGF 164 than in those of the control (P<0.05). In contrast, the numbers of atretic follicles in rats treated with VEGF 120 or 164 isoforms were lower than those in the control (Table 1) . Serum 17β-estradiol concentration was significantly higher in rats treated with VEGF 120 or 164 isoforms than in the control (Fig. 2) .
Effect of VEGF isoforms on ovulation:
Treatment with different VEGF isoforms affected the numbers of oocytes ovulated in a dosedependent manner (Fig. 3) . The numbers of oocytes ovulated in rats treated with 0.8 µg/kg of VEGF 120 or 8.0 µg/kg of VEGF 164 were higher than those in rats treated at other doses and in the control (P<0.05).
Normality of ovulated oocytes:
There were no significant differences in fertilization and degeneration of oocytes in rats regardless of VEGF isoform treatment (data not shown). All female rats injected with 0.8 µg/kg of VEGF 120 or 8.0 µg/kg of VEGF 164 became pregnant after pairing with males, and delivered normal litters. The body weight average of newborn rats from the rats treated with VEGF 164 was markedly lower than those of newborns of the rats treated with VEGF120 and the control, although there was no significant difference in the litter size among the groups (Table 2) .
Discussion
In the present study, we demonstrate for the first time the effects of an angiogenic inhibitor and different VEGF isoforms on follicular development and ovulation. The angiogenic inhibitor showed severe depression of follicular angiogenesis with complete inhibition of ovulation, whereas VEGF isoforms promoted ovarian follicular angiogenesis in the theca interna layer leading to stimulatory effects on subsequent follicular development and ovulation in mature cycling rats. In addition, the oocytes ovulated in rats treated with VEGFs had n o r m a l f e r t i l i z a b i l i t y a n d d e v e l o p m e n t a l competence to term. Ovarian follicular angiogenesis is initiated at the early stages of follicular development [3] , and blood vessels in the thecal layer increase in number and size as the follicles develop [25, 30] , indicating a strong association between angiogenesis and follicular development. In the present study, the examination of corrosion casts demonstrated that more active angiogenesis was observed in the preovulatory follicles of rats treated with VEGF isoforms. Active angiogenesis, as indicated morphologically by the presence of both budding and sprouting capillaries, was more evident in the largest follicles. The present results are consistent with those of previous reports [25, 31] . The treatment of mature rats with an angiogenic in hibitor resulte d in severe de pression of angiogenesis and complete inhibition of ovulation, and considered together with the results of previous reports the present findings appear to show direct evidence that follicular angiogenesis is a determinant of the follicular growth during the ovarian cycle.
Recent studies have shown that injection of VEGF proteins or VEGF gene fragments into the ovaries increases the numbers of small follicles in immature rats or large preovulatory follicles in miniature gilts [32, 33] . The VEGF gene codes several VEGF isoforms by alternative splicing [5] , and different isoforms have been reported to exhibit distinct biological activities [34, 35] and expression levels in different tissues or the same tissue at various stages [36] . The stability of VEGF is different among VEGF isoforms, which is important for the physiological functions [37] . The expression of two VEGF isoforms (VEGF 120 and 164) was detected in ovarian tissues, and their expression levels changed during follicular development. In adult mouse ovaries, the expression level of VEGF 164 mRNA was higher than that of VEGF 120 mRNA [36] . However, the expression level of VEGF 120 mRNA was higher than that of VEGF 164 mRNA in medium and large follicles of porcine ovaries after equine chorionic gonadotropin treatment [5] . Although both VEGF120 and164 can induce endothelial cell proliferation and increase permeability, differences in their heparin-binding properties, potencies and tissue distribution have been reported [20, 24, 38] . VEGF 120 and 164 isoforms have different affinities for the VEGF receptors Flt-1, Flk-1 and neuropilin-1, suggesting that VEGF isoforms may play distinct roles in vascular development [36] . However, the detailed biological differences between these two isoforms during follicular development remain unknown. In the present study, we showed that treatment with VEGF 120 at a lower dose (0.8 µg/ kg) or VEGF 164 at a higher dose (8.0 µg/kg) markedly stimulated follicular angiogenesis in the theca interna layer, and increased the numbers of healthy preovulatory follicles and of oocytes ovulated in the rats. This suggests that these two isoforms have different function with respect to the regulation of ovarian follicular angiogenesis and development. VEGF120 may have higher affinity to its receptor(s) or greater stability or physiological activity, while VEGF164 may have lower affinity to i t s r e c e p t o r ( s ) o r d e c r e a s e d s t a b i l i t y o r physiological activity. Further investigations are needed to address the detailed mechanisms regulating the expression and stability of different VEGF isoforms. Recent evidence indicates that VEGF may have survival effects on granulosa cells in vitro and follicular health in vivo [39] . In the present study, serum 17β-estradiol concentrations in rats treated with VEGF 120 and 164 were significantly higher than that in the control rats, indicating that VEGF 120 and 164 may indirectly stimulate the production of 17β-estradiol by granulosa cells.
To determine the quality of the oocytes ovulated by rats injected with VEGF isoforms, the treated animals were mated after the injection and allowed to proceed through pregnancy. There was no difference in litter size among any of treatment groups, providing evidence that injection of VEGF proteins has no effect on the quality of ovulated oocytes.
In conclusion, we demonstrated that follicular angiogenesis could be one of the key determinants for follicular development during the periovulatory growth and development phase. Treatment of rats with different VEGF isoforms promoted ovarian follicular angiogenesis, stimulated follicular development and increased the number of o v u l a t e d o o c y t e s , w h i c h s h o w e d n o r m a l fertilizability and developmental competence to term. The present data suggest that injection of VEGF proteins may contribute to the development of a novel therapeutic method for ovarian dysfunction.
